Microbiota changes induced by microencapsulated sodium butyrate in patients with inflammatory bowel disease.

Microbiota changes induced by microencapsulated sodium butyrate in patients with inflammatory bowel disease.
复制标题

DOI:
10.1111/nmo.13914
复制
发表时间:
2020-10
影响因子:
3.5
通讯作者:
Savarino EV
Savarino EV
中科院分区:
医学3区
文献类型:
--
作者:
Facchin S;Vitulo N;Calgaro M;Buda A;Romualdi C;Pohl D;Perini B;Lorenzon G;Marinelli C;D'Incà R;Sturniolo GC;Savarino EV

文献摘要

参考文献

被引文献

相似文献

Butyrate has shown anti‐inflammatory and regenerative properties, providing symptomatic relief when orally supplemented in patients suffering from various colonic diseases. We investigated the effect of a colonic‐delivery formulation of butyrate on the fecal microbiota of patients with inflammatory bowel diseases (IBDs). In this double‐blind, placebo‐controlled, pilot study, 49 IBD patients (n = 19 Crohn's disease, CD and n = 30 ulcerative colitis, UC) were randomized to oral administration of microencapsulated‐sodium‐butyrate (BLM) or placebo for 2 months, in addition to conventional therapy. Eighteen healthy volunteers (HVs) were recruited to provide a healthy microbiota model of the local people. Fecal microbiota from stool samples was assessed by 16S sequencing. Clinical disease activity and quality of life (QoL) were evaluated before and after treatment. At baseline, HVs showed a different microbiota composition compared with IBD patients. Sodium‐butyrate altered the gut microbiota of IBD patients by increasing bacteria able to produce SCFA in UC patients (Lachnospiraceae spp.) and the butyrogenic colonic bacteria in CD patients (Butyricicoccus). In UC patients, QoL was positively affected by treatment. Sodium‐butyrate supplementation increases the growth of bacteria able to produce SCFA with potentially anti‐inflammatory action. The clinical impact of this finding requires further investigation. We evaluated the effect of a sodium butyrate microencapsulated oral formulation on the gut microbiota of IBD patients. The butyrate can modulate the gut bacteria, stimulating the growth of butyrogenic and SCFA genera.
DOI: 10.1038/ajg.2010.281
发表时间: 2010-11-01
影响因子: 9.8
作者:
Png, Chin Wen;Linden, Sara K.;Florin, Timothy H. J.
通讯作者: Florin, Timothy H. J.
DOI: 10.1038/nmeth.3869
发表时间: 2016-07
期刊: Nature methods
影响因子: 48
作者:
Callahan BJ;McMurdie PJ;Rosen MJ;Han AW;Johnson AJ;Holmes SP
通讯作者: Holmes SP
DOI: 10.1111/j.1365-2982.2011.01775.x
发表时间: 2011-11
影响因子: 3.5
作者:
Kannampalli P;Shaker R;Sengupta JN
通讯作者: Sengupta JN
DOI: 10.1371/journal.pbio.2006842
发表时间: 2018-12
期刊: PLoS biology
影响因子: 9.8
作者:
Brooks AW;Priya S;Blekhman R;Bordenstein SR
通讯作者: Bordenstein SR
DOI: 10.1136/gutjnl-2013-304833
发表时间: 2014-08-01
期刊: GUT
影响因子: 24.5
作者:
Machiels, Kathleen;Joossens, Marie;Vermeire, Severine
通讯作者: Vermeire, Severine